199 related articles for article (PubMed ID: 17553037)
21. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.
Black RJ; Gavin AT
Br J Dermatol; 2006 Mar; 154(3):566-7. PubMed ID: 16445801
[No Abstract] [Full Text] [Related]
22. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
23. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
24. Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.
Feldmeyer L; Shojaati G; Spanaus KS; Navarini A; Theler B; Donghi D; Urosevic-Maiwald M; Glatz M; Imhof L; Barysch MJ; Dummer R; Roos M; French LE; Surber C; Hofbauer GF
J Am Acad Dermatol; 2013 Oct; 69(4):530-6. PubMed ID: 23850091
[TBL] [Abstract][Full Text] [Related]
25. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis.
Köllner K; Wimmershoff MB; Hintz C; Landthaler M; Hohenleutner U
Br J Dermatol; 2005 Apr; 152(4):750-4. PubMed ID: 15840108
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
28. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: a systematic review of the literature.
Pasker-de Jong PC; Wielink G; van der Valk PG; van der Wilt GJ
Arch Dermatol; 1999 Jul; 135(7):834-40. PubMed ID: 10411159
[TBL] [Abstract][Full Text] [Related]
29. Phototherapy of psoriasis - clinical aspects and risk evaluation.
Larkö O
Acta Derm Venereol Suppl (Stockh); 1982; 103():1-42. PubMed ID: 6964661
[TBL] [Abstract][Full Text] [Related]
30. UVB phototherapy and skin cancer risk: a review of the literature.
Lee E; Koo J; Berger T
Int J Dermatol; 2005 May; 44(5):355-60. PubMed ID: 15869531
[TBL] [Abstract][Full Text] [Related]
31. Remission period in psoriasis after multiple cycles of narrowband ultraviolet B phototherapy.
Ryu HH; Choe YS; Jo S; Youn JI; Jo SJ
J Dermatol; 2014 Jul; 41(7):622-7. PubMed ID: 24942986
[TBL] [Abstract][Full Text] [Related]
32. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?
Pugashetti R; Lim HW; Koo J
J Dermatolog Treat; 2010 Nov; 21(6):326-30. PubMed ID: 19895327
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
Chao CH; Wu CY; Chou FL; Chen YJ
Clin Exp Dermatol; 2024 Apr; 49(5):459-465. PubMed ID: 38056487
[TBL] [Abstract][Full Text] [Related]
34. UVB doses in maintenance psoriasis phototherapy versus solar UVB exposure.
Schothorst AA; Slaper H; Schouten R; Suurmond D
Photodermatol; 1985 Aug; 2(4):213-20. PubMed ID: 4059077
[TBL] [Abstract][Full Text] [Related]
35. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
36. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis?
Pavlovsky M; Baum S; Shpiro D; Pavlovsky L; Pavlotsky F
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):727-9. PubMed ID: 20726938
[TBL] [Abstract][Full Text] [Related]
37. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
Werfel T; Holiangu F; Niemann KH; Schmerling O; Lüllau F; Zedler A; Sträter HD; Niebuhr M
Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
[TBL] [Abstract][Full Text] [Related]
38. An assessment of potential problems of home phototherapy treatment of psoriasis.
Feldman SR; Clark A; Reboussin DM; Fleischer AB
Cutis; 1996 Jul; 58(1):71-3. PubMed ID: 8823554
[TBL] [Abstract][Full Text] [Related]
39. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.
Pittelkow MR; Perry HO; Muller SA; Maughan WZ; O'Brien PC
Arch Dermatol; 1981 Aug; 117(8):465-8. PubMed ID: 7259240
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
Asawanonda P; Nateetongrungsak Y
J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
